financetom
Business
financetom
/
Business
/
Crane NXT Expects Currency Technology Business to Grow
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crane NXT Expects Currency Technology Business to Grow
Sep 23, 2025 5:16 AM

07:55 AM EDT, 09/23/2025 (MT Newswires) -- Crane NXT ( CXT ) said Tuesday that it expects its US currency technology business to grow in the high-single-digits in 2026 based on the Federal Reserve Board's 2026 print order.

The 2026 print order projects a range of 3.8 billion to 5.1 billion in banknote demand with the volume of higher denomination banknotes increasing around 90% at the midpoint compared with 2025, the company said.

This increase is partially offset by a decrease in expected volumes for lower denomination banknotes of $5 and below, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enphase Energy to lay off 17% of workforce
Enphase Energy to lay off 17% of workforce
Nov 9, 2024
(Reuters) -Enphase Energy will cut its global workforce by about 17%, impacting about 500 employees and contractors, the solar inverter maker disclosed in a filing on Friday. Enphase will also streamline its operations by focusing contract manufacturing in four existing locations - two in the United States, one in India and one in China. The company will cease its contract...
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Nov 9, 2024
04:23 PM EST, 11/08/2024 (MT Newswires) -- Giuseppe Ciaramella, President, on November 06, 2024, sold 51,110 shares in Beam Therapeutics ( BEAM ) for $1,347,050. Following the Form 4 filing with the SEC, Ciaramella has control over a total of 109,150 shares of the company, with 109,150 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1745999/000095017024124085/xslF345X05/ownership.xml ...
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Nov 9, 2024
04:01 PM EST, 11/08/2024 (MT Newswires) -- Brian J Lipke, Director, on November 07, 2024, sold 1,343 shares in Moog ( MOG/A ) (MOGA, MOGB) for $298,979. Following the Form 4 filing with the SEC, Lipke has control over a total of 19,765 shares of the company, with 19,765 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/67887/000006788724000085/xslF345X05/wk-form4_1731099060.xml ...
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Nov 9, 2024
04:53 PM EST, 11/08/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said late Friday that preclinical data for its CAR T-cell candidate FT836 demonstrated the product's potential for durable anti-tumor activity without intervention. The data support the pan-cancer activity of MICA/B targeting, and indicate that our next-generation, iPSC-derived CAR T-cell platform has the potential to drive potent and durable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved